Alina, was then working as a teacher at a secondary school in Kajang, Selangor. Initially, she thought her condition was due ...

The myasthenia gravis treatment market is anticipated to grow at a CAGR of 7.14% from US$1.973 billion in 2025 to US$2.785 ...

Ultomiris (ravulizumab-cwvz) is a brand-name infusion prescribed for myasthenia gravis. This article covers topics such as side effects, dosage, and how Ultomiris works. Ultomiris is an ...

MG-ADL scores improved, indicating enhanced daily functioning for patients with myasthenia gravis. Limitations include potential coding errors, selection biases, and missing clinical data ...

The FDA has approved Alexion's Soliris for use in patients with treatment resistant generalised Myasthenia gravis (gMG), making it the first new therapy for the condition in 60 years. The approval ...

she was diagnosed with myasthenia gravis (MG), a rare autoimmune disease. “I didn’t know what to feel – relieved because I finally knew the cause or afraid because I had never even heard of the ...

Credit: Getty Images In a phase 3 clinical trial, researchers assessed the efficacy and safety of inebilizumab in patients with generalized myasthenia gravis. At Week 26, compared to the placebo ...

SAN DIEGO -- Inebilizumab (Uplizna) improved function and reduced disease severity for up to 52 weeks in generalized myasthenia gravis (gMG) patients who were acetylcholine receptor (AChR ...

Myasthenia gravis, or MG for short, is a chronic autoimmune disorder that causes weakness ... With their guidance and the right treatments like mestinon and prednisone when needed, I was able to have ...